M&A Deal Summary |
|
---|---|
Date | 2017-01-04 |
Target | BioControl Systems |
Sector | Life Science |
Buyer(s) | Merck |
Deal Type | Add-on Acquisition |
Advisor(s) | Achelous Partners LLC (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1668 |
Sector | Diversified |
Employees | 64,011 |
Revenue | 21.0B EUR (2023) |
Merck is a science and technology company in healthcare, life science, and performance materials. Merck develops technologies that improve and enhance life from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Merck was founded in 1668 and is based in Darmstadt, Germany.
DEAL STATS | # |
---|---|
Overall | 17 of 24 |
Sector (Life Science) | 7 of 10 |
Type (Add-on Acquisition) | 13 of 20 |
State (Washington) | 2 of 2 |
Country (United States) | 7 of 10 |
Year (2017) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-12-14 |
Ormet Circuits
San Diego, California, United States Ormet Circuits, Incorporated (Ormet) is a privately held company, engaged in the design, manufacture, and sale of electrically conductive sintering pastes for use in the assembly of advanced electronic devices. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-08-28 |
Natrix Separations
Burlington, Ontario, Canada Natrix Separations, Inc. is a provider of hydrogel membrane products for single-use chromatography. Natrix products feature well-established industry-standard chemistries, and are scalable from R&D to commercial manufacturing. Natrix is headquartered in Burlington, Ontario, Canada. |
Buy | - |